NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue

CompletedNA

Sponsor: Dana-Farber Cancer Institute

Conditions: Ovarian Cancer, Fatigue, Coping Behavior, Coping Skills

Interventions: Enhanced Usual Care (EOC), REVITALIZE ACT Intervention

Countries: United States

This study is testing whether a 6 week skills-based telehealth intervention can help ovarian cancer patients experiencing PARP inhibitor-related fatigue reduce the impact of fatigue on their daily life and activities.

Eligibility overview

Sex: FEMALE

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Women ≥18 years of age who have been diagnosed with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.
* Receiving PARPI inhibitors for ≥ 2 months.
* Able to read/speak English.
* Have an Eastern Oncology Group (ECOG) performance of 0-2.
* Report moderate-severe fatigue in the past week (average score ≥4 on a Fatigue Symptom Inventory scale of 0-10)

Exclusion Criteria:

* Patients with an untreated clinical condition or comorbid illness (e.g. anemia, hypothyroidism) that could explain their fatigue.
* Patients with chronic severe fatigue that pre-dates their use of PARPi.
* The following special populations will be excluded from this research:

  * Adults unable to consent
  * Individuals who are not yet adults (infants, children, teenagers)
  * Pregnant women
  * Prisoners

Locations (2)

Boston, Massachusetts, United States
Philadelphia, Pennsylvania, United States